Works matching DE "MYELODYSPLASTIC syndromes treatment"
Results: 446
A case of unilateral neutrophilic dermatosis of the dorsal hands.
- Published in:
- Portuguese Journal of Dermatology & Venereology, 2023, v. 81, n. 2, p. 137, doi. 10.24875/PJDV.22000040
- By:
- Publication type:
- Article
In Brief.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 4, p. 235, doi. 10.1093/jnci/djj087
- Publication type:
- Article
MOLECULARY CONFIRMED, CYTOGENETIC REMISSION IN A CASE WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDNE.
- Published in:
- Contributions / Prilozi (1857-9345), 2017, v. 38, n. 3, p. 157, doi. 10.2478/prilozi-2018-0017
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 296, doi. 10.1038/bmt.2014.233
- By:
- Publication type:
- Article
Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 8, p. 1022, doi. 10.1038/bmt.2014.87
- By:
- Publication type:
- Article
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 5, p. 677, doi. 10.1038/bmt.2011.168
- By:
- Publication type:
- Article
Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 4, p. 502, doi. 10.1038/bmt.2010.153
- By:
- Publication type:
- Article
Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene.
- Published in:
- 2016
- By:
- Publication type:
- journal article
SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5q.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Is Disease-Specific Immunotherapy a Potential Reality for MDS?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
- Published in:
- Acta Haematologica, 2017, v. 138, n. 1, p. 39, doi. 10.1159/000477530
- By:
- Publication type:
- Article
Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis.
- Published in:
- Acta Haematologica, 2016, v. 136, n. 1, p. 23, doi. 10.1159/000445163
- By:
- Publication type:
- Article
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 4, p. 233, doi. 10.1159/000381893
- By:
- Publication type:
- Article
Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 3, p. 135, doi. 10.1159/000371833
- By:
- Publication type:
- Article
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 3, p. 138, doi. 10.1159/000370097
- By:
- Publication type:
- Article
Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?
- Published in:
- Acta Haematologica, 2015, v. 134, n. 1, p. 38, doi. 10.1159/000369243
- By:
- Publication type:
- Article
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 1, p. 40, doi. 10.1159/000368711
- By:
- Publication type:
- Article
Complete Response of Myeloid Sarcoma with FIPTL1-PDGFRA-/Kssoc\ated Myeloproliferative Neoplasms to Imatinib Mesylate Monotherap.
- Published in:
- Acta Haematologica, 2012, v. 128, n. 2, p. 83, doi. 10.1159/000338217
- By:
- Publication type:
- Article
Reduced-Intensity Conditioning Regimen Combined with Low-Dose Total Body Irradiation in the Treatment of Myelodysplastic Syndrome.
- Published in:
- Acta Haematologica, 2011, v. 126, n. 1, p. 21, doi. 10.1159/000323717
- By:
- Publication type:
- Article
Detection of dysplasia in peripheral blood: Proposal of an algorithm to detect myelodysplastic syndromes and chronic myelomonocytic leukemias on a high‐speed technical platform using the Sysmex XN™ analyser.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 2, p. 286, doi. 10.1111/ijlh.14217
- By:
- Publication type:
- Article
Spontaneous resolution of "therapy‐related myelodysplasia" occurred after treatment with CAR‐T cells: All that glitters is not gold.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Full spectral flow cytometry analysis of the bone marrow immune cells in patients with myelodysplastic syndrome.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 1, p. e10, doi. 10.1111/ijlh.13945
- By:
- Publication type:
- Article
Abrupt thrombocytopenia with sustained trilineage engraftment in a stem cell transplant recipient.
- Published in:
- International Journal of Laboratory Hematology, 2015, v. 37, n. 5, p. e106, doi. 10.1111/ijlh.12338
- By:
- Publication type:
- Article
The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
- Published in:
- International Journal of Laboratory Hematology, 2015, v. 37, p. 115, doi. 10.1111/ijlh.12361
- By:
- Publication type:
- Article
A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low-risk’ myelodysplasia.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 4, p. 679, doi. 10.1046/j.1365-2141.2003.04136.x
- By:
- Publication type:
- Article
Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 2, p. 334, doi. 10.1046/j.1365-2141.2002.03279.x
- By:
- Publication type:
- Article
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2001, v. 115, n. 4, p. 881, doi. 10.1046/j.1365-2141.2001.03204.x
- By:
- Publication type:
- Article
Haematopoietic stem cell transplantation for patients with myelo‐dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 3, p. 620, doi. 10.1046/j.1365-2141.2000.02200.x
- By:
- Publication type:
- Article
CALCITRIOL IN MYELODYSPLASTIC SYNDROMES.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 2, p. 572, doi. 10.1046/j.1365-2141.1999.01621.x
- By:
- Publication type:
- Article
rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 2, p. 573, doi. 10.1046/j.1365-2141.1999.01622.x
- By:
- Publication type:
- Article
rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 2, p. 574, doi. 10.1046/j.1365-2141.1999.1622a.x
- By:
- Publication type:
- Article
Clofibric acid: a potential therapeutic agent in AML and MDS.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 2, p. 448, doi. 10.1111/j.1365-2141.1999.01355.x
- By:
- Publication type:
- Article
Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2′-deoxyadenosine.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 1, p. 268, doi. 10.1046/j.1365-2141.1999.01277.x
- By:
- Publication type:
- Article
Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 1, p. 141, doi. 10.1111/j.1365-2141.1999.01313.x
- By:
- Publication type:
- Article
Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation.
- Published in:
- British Journal of Haematology, 1999, v. 104, n. 3, p. 569, doi. 10.1046/j.1365-2141.1999.01205.x
- By:
- Publication type:
- Article
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 4, p. 1070, doi. 10.1046/j.1365-2141.1998.01085.x
- By:
- Publication type:
- Article
Poor response rate to a continuous schedule of Amifostine therapy for ‘low/intermediate risk’ myelodysplastic patients.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 3, p. 785, doi. 10.1046/j.1365-2141.1998.01045.x
- By:
- Publication type:
- Article
Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 3, p. 778, doi. 10.1046/j.1365-2141.1998.01054.x
- By:
- Publication type:
- Article
Vitamin D treatment in myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 3, p. 516, doi. 10.1046/j.1365-2141.1998.00598.x
- By:
- Publication type:
- Article
Iron chelation therapy in myelodysplastic syndromes.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, p. S10, doi. 10.2146/ajhp090654
- By:
- Publication type:
- Article
Myelodysplastic syndromes and the role of iron overload.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, p. S3, doi. 10.2146/ajhp090645
- By:
- Publication type:
- Article
Iron overload in myelodysplastic syndromes.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, p. S2, doi. 10.2146/ajhp100043
- By:
- Publication type:
- Article